Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for...
Our Mission At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases with a focus on specialty markets. Meet our leadership The values that drive us It’s not just about what we do, but how we do it. Our values are our bedrock and ...
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $286.02, moving -0.96% from the previous trading session. This change lagged the S&P 500's 0.4% loss on the day. Elsewhere, the Dow lost 0.03%, while the tech-heavy Nasdaq lost 4.72%. Coming into today, shares...
Vertex is proud to be a certified Great Place to Work. This recognition comes directly from employees and their experience — our intellectual curiosity and unwavering commitment to patients drive our work and our culture. The Boston Globe
Vertex Pharmaceuticals(NASDAQ: VRTX) Q2 2024 Earnings Call Aug 01, 2024,4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, and welcome to the Vertex pharmaceuticals second-quarter 2024earnings call[Operator instructions] Please note ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 11:20 AM ET Company Participants David Altshuler - Chief Scientific Officer Charles Wagner - CFO Confere...
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical partner...
August 1, 2024 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the “Vertex Pharmaceuticals Second Quarter 2024 Earnings...
10, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a biotechnology company focused on discovering and developing innovative, protein-based immunotherapies, today announced that the companies have entered into a definitive agreement und...
Get Vertex Pharmaceuticals Inc (VRTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.